Analysis of SGPP1 expression of the same newly diagnosed MM patients showed a significant association of higher levels of SGPP1 expression with longer patient survival after the first 30 months of the study length, which suggests that in patients, lower S1P levels due to higher SGPP1 activity decreases MM cell viability. Here, SGPP1 is linked to Miyoshi myopathy.